Device, Systems and Methods for Treatment of Neurogenic Bladder
A patent family: one line of work, grouped by real continuity rather than by a technology label
inferred from titles. 2 of these applications claim priority to application 62/754,433, filed Nov 1, 2018. A shared origin can cover several different claimed inventions, which is why members here may not share a title. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
| Patent | Title | Holder | Status | Expires | Time remaining | Confidence |
|---|---|---|---|---|---|---|
| US 12,133,980 | Device, Systems and Methods for Treatment of Neurogenic Bladder In force · Medium confidence | Incube Labs, LLC | In force | Medium confidence | ||
| US 11,794,001 | Device, Systems and Methods for Treatment of Neurogenic Bladder In force · High confidence | Incube Labs, LLC | In force | High confidence | ||
| Application 18/904,817 | Device, Systems and Methods for Treatment of Neurogenic Bladder Pending Not granted | Incube Labs, LLC | Pending | Not granted |
3 of 3 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
2 of these are in force and held by Incube Labs, LLC.
Updated Nov 17, 2026 · includes USPTO assignment data published Nov 16, 2026, status data published Nov 17, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.